{1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-bis(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]-1H-1,2,3-triazol-4-yl}methyl 4-sulfamoylbenzoate

InChIKey	`ANFIQSWBRXIYBF-GNJRFXKQSA-N`
Compound Name	{1-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-bis(acetyloxy)-6-[(acetyloxy)methyl]oxan-2-yl]-1H-1,2,3-triazol-4-yl}methyl 4-sulfamoylbenzoate
Canonical SMILES	`CC(=O)N[C@@H]1[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O[C@H]1n1cc(COC(=O)c2ccc(S(N)(=O)=O)cc2)nn1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	7.22
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
O43570	CA12	Homo sapiens	Human	PF00194	8.4	Ki	ChEMBL;BindingDB
Q9ULX7	CA14	Homo sapiens	Human	PF00194	7.2	Ki	ChEMBL;BindingDB
P00918	CA2	Homo sapiens	Human	PF00194	6.7	Ki	ChEMBL;BindingDB
P18505	GABRB1	Homo sapiens	Human	PF02931 PF02932	6.7	pIC50	TTD_MultiTarget